Detection and Clinical Significance of CD44v6 and Integrin-β1 in Pancreatic Cancer Patients using a Triplex Real-Time RT-PCR Assay

The cell adhesion molecules CD44v6 and integrin-β1 are associated with the progression and metastasis of cancer. A novel triplex real-time reverse transcription polymerase chain reaction (qRT-PCR) assay was developed to quantify CD44v6 and integrin-β1 gene expression in peripheral blood mononuclear cells from 30 pancreatic cancer (PC) patients and 12 healthy individuals. The standard curve of the triplex qRT-PCR was constructed by optimizing the reaction condition and the amplification efficiency was 102.5, 101.1, and 100.6 % for CD44v6, integrin-β1 and endogenous gene (β-actin) amplification. Nonspecific bands were not observed from the triplex qRT-PCR amplification and the detection limit of this assay was 100 copies. Expression levels of CD44v6 and integrin-β1 gene were significantly lower in healthy individuals than PC patients (P < 0.05). CD44v6 and integrin-β1 gene expression were not associated with the sex, age, and tumor position in PC (P > 0.05). CD44v6 gene expression was significantly associated with clinical stage, liver metastasis, and tumor size (P < 0.05). Integrin-β1 gene expression was significantly associated with clinical stage and liver metastasis (P < 0.05). This triplex qRT-PCR assay may provide a useful tool for diagnosis, prognosis, and therapeutic evaluation in PC.

[1]  N. Matsuura,et al.  Increased expression of integrin alpha3beta1 in highly brain metastatic subclone of a human non-small cell lung cancer cell line. , 2004, Cancer Science.

[2]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[3]  M. Zöller,et al.  CD44v6 Coordinates Tumor Matrix-triggered Motility and Apoptosis Resistance* , 2011, The Journal of Biological Chemistry.

[4]  J. Kanzaki,et al.  Role of CD44 variant exon 6 in invasion of head and neck squamous cell carcinoma. , 2000, Archives of otolaryngology--head & neck surgery.

[5]  Richard O. Hynes,et al.  Integrins: Versatility, modulation, and signaling in cell adhesion , 1992, Cell.

[6]  K. Hioki,et al.  Increased expression of CD44v6 mRNA significantly correlates with distant metastasis and poor prognosis in gastric cancer , 1998, International journal of cancer.

[7]  K. Hirata,et al.  Current Status of Surgery for Pancreatic Cancer , 2007, Digestive Surgery.

[8]  C. Haglund,et al.  Does anyone survive pancreatic ductal adenocarcinoma? A nationwide study re-evaluating the data of the Finnish Cancer Registry , 2005, Gut.

[9]  N. Niitsu,et al.  High serum soluble CD44 is correlated with a poor outcome of aggressive non-Hodgkin's lymphoma. , 2002, Leukemia research.

[10]  T. Mak,et al.  Absence of the CD44 gene prevents sarcoma metastasis. , 2002, Cancer research.

[11]  A. Jemal,et al.  Cancer Statistics, 2006 , 2006, CA: a cancer journal for clinicians.

[12]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[13]  David S. Harburger,et al.  Integrin signalling at a glance , 2009, Journal of Cell Science.

[14]  A. Herrero,et al.  Expression of E-cadherin, CD44s, and CD44v6 in laryngeal and pharyngeal carcinomas. , 2003, American journal of otolaryngology.

[15]  S. Holly,et al.  Multiple roles of integrins in cell motility. , 2000, Experimental cell research.

[16]  S. Albelda,et al.  Role of integrins and other cell adhesion molecules in tumor progression and metastasis. , 1993, Laboratory investigation; a journal of technical methods and pathology.

[17]  Han-guang Zhu,et al.  Expression of E-cadherin in cervical lymph nodes from primary oral squamous cell carcinoma patients. , 2007, Archives of oral biology.

[18]  R. Weinberg,et al.  Integrin β1-focal adhesion kinase signaling directs the proliferation of metastatic cancer cells disseminated in the lungs , 2009, Proceedings of the National Academy of Sciences.

[19]  R. Hruban,et al.  Aberrant MicroRNA-155 Expression Is an Early Event in the Multistep Progression of Pancreatic Adenocarcinoma , 2010, Pancreatology.

[20]  Hui Zhang,et al.  Increased beta1 integrin is associated with decreased survival in invasive breast cancer. , 2007, Cancer research.

[21]  H. Friess,et al.  Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma , 2004, The British journal of surgery.

[22]  B. Mack,et al.  CD44s and CD44v6 Expression in Head and Neck Epithelia , 2008, PloS one.

[23]  S. Tsujitani,et al.  Serum concentration of CD44 variant 6 and its relation to prognosis in patients with gastric carcinoma , 1998, Cancer.

[24]  L. Ylagan,et al.  Cd44: a marker of squamous differentiation in adenosquamous neoplasms. , 2000, Archives of pathology & laboratory medicine.

[25]  Z. Ling,et al.  Expression of E-selectin, integrin beta1 and immunoglobulin superfamily member in human gastric carcinoma cells and its clinicopathologic significance. , 2006, World journal of gastroenterology.

[26]  J. Liu,et al.  Expression of hyaluronan receptors CD44 and RHAMM in stomach cancers: relevance with tumor progression. , 2000, International journal of oncology.

[27]  F. Vizoso,et al.  Expression and clinical significance of CD44V5 and CD44V6 in resectable colorectal cancer , 2004, Journal of Cancer Research and Clinical Oncology.

[28]  Dan H. Moore,et al.  Increased β1 Integrin Is Associated with Decreased Survival in Invasive Breast Cancer , 2007 .

[29]  P. Leung,et al.  Integrin β1 mediates epithelial growth factor-induced invasion in human ovarian cancer cells. , 2012, Cancer letters.

[30]  J. Niu,et al.  Integrin alphavbeta6 mediates the potential for colon cancer cells to colonize in and metastasize to the liver , 2008, Cancer science.

[31]  K. Kondo,et al.  The expression of the CD44 variant exon 6 is associated with lymph node metastasis in non-small cell lung cancer. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[32]  W. Muller,et al.  Targeted disruption of beta1-integrin in a transgenic mouse model of human breast cancer reveals an essential role in mammary tumor induction. , 2004, Cancer cell.

[33]  I. Saloniemi,et al.  CD44v6 in developing, dysplastic and malignant oral epithelia. , 2003, Oral oncology.

[34]  A. Belldegrun,et al.  Absent CD44v6 expression is an independent predictor of poor urothelial bladder cancer outcome. , 2010, The Journal of urology.

[35]  Qing Luo,et al.  Mesenchymal stem cells require integrin β1 for directed migration induced by osteopontin in vitro , 2011, In Vitro Cellular & Developmental Biology - Animal.

[36]  J. Thiery,et al.  Real‐time quantitative PCR determination of urokinase‐type plasminogen activator receptor (uPAR) expression of isolated micrometastatic cells from bone marrow of breast cancer patients , 2005, International journal of cancer.